Article Details

IgGenix Demonstrates Potential of IGNX001 as a Targeted Therapeutic for Peanut Allergy at ...

Retrieved on: 2024-06-03 13:27:19

Tags for this article:

Click the tags to see associated articles and topics

IgGenix Demonstrates Potential of IGNX001 as a Targeted Therapeutic for Peanut Allergy at .... View article details on hiswai:

Excerpt

... monoclonal antibody-based therapeutic candidate for peanut allergy. The company also presented data in Atopic Dermatitis (AD), showcasing the ...

Article found on: www.fox44news.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up